These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 32218505)

  • 1. Targeted gene therapy into a safe harbor site in human hematopoietic progenitor cells.
    Rodriguez-Fornes F; Quintana-Bustamante O; Lozano ML; Segovia JC; Bueren JA; Guenechea G
    Gene Ther; 2020 Sep; 27(9):435-450. PubMed ID: 32218505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA.
    Quintana-Bustamante O; Fañanas-Baquero S; Orman I; Torres R; Duchateau P; Poirot L; Gouble A; Bueren JA; Segovia JC
    PLoS One; 2019; 14(10):e0223775. PubMed ID: 31618280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription activator-like effector nuclease (TALEN)-mediated CLYBL targeting enables enhanced transgene expression and one-step generation of dual reporter human induced pluripotent stem cell (iPSC) and neural stem cell (NSC) lines.
    Cerbini T; Funahashi R; Luo Y; Liu C; Park K; Rao M; Malik N; Zou J
    PLoS One; 2015; 10(1):e0116032. PubMed ID: 25587899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TALEN-mediated intron editing of HSPCs enables transgene expression restricted to the myeloid lineage.
    Seclen E; Jang JC; Lawal AO; Pulicani S; Boyne A; Tkach D; Juillerat A; Duchateau P; Valton J
    Mol Ther; 2024 Jun; 32(6):1643-1657. PubMed ID: 38582963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TALEN mediated gene editing in a mouse model of Fanconi anemia.
    Pino-Barrio MJ; Giménez Y; Villanueva M; Hildenbeutel M; Sánchez-Dominguez R; Rodríguez-Perales S; Pujol R; Surrallés J; Río P; Cathomen T; Mussolino C; Bueren JA; Navarro S
    Sci Rep; 2020 Apr; 10(1):6997. PubMed ID: 32332829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Transgene Silencing of Myeloid-Specific Promoters in the
    Klatt D; Cheng E; Hoffmann D; Santilli G; Thrasher AJ; Brendel C; Schambach A
    Hum Gene Ther; 2020 Feb; 31(3-4):199-210. PubMed ID: 31773990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted transgene insertion into the AAVS1 locus driven by baculoviral vector-mediated zinc finger nuclease expression in human-induced pluripotent stem cells.
    Tay FC; Tan WK; Goh SL; Ramachandra CJ; Lau CH; Zhu H; Chen C; Du S; Phang RZ; Shahbazi M; Fan W; Wang S
    J Gene Med; 2013 Oct; 15(10):384-95. PubMed ID: 24105820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UMG Lenti: novel lentiviral vectors for efficient transgene- and reporter gene expression in human early hematopoietic progenitors.
    Chiarella E; Carrà G; Scicchitano S; Codispoti B; Mega T; Lupia M; Pelaggi D; Marafioti MG; Aloisio A; Giordano M; Nappo G; Spoleti CB; Grillone T; Giovannone ED; Spina R; Bernaudo F; Moore MA; Bond HM; Mesuraca M; Morrone G
    PLoS One; 2014; 9(12):e114795. PubMed ID: 25502183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine transgene expression and promoter usage in primary CD34+ cells using particle-mediated gene delivery.
    Ye ZQ; Qiu P; Burkholder JK; Turner J; Culp J; Roberts T; Shahidi NT; Yang NS
    Hum Gene Ther; 1998 Oct; 9(15):2197-205. PubMed ID: 9794204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas-and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells.
    Patsali P; Turchiano G; Papasavva P; Romito M; Loucari CC; Stephanou C; Christou S; Sitarou M; Mussolino C; Cornu TI; Antoniou MN; Lederer CW; Cathomen T; Kleanthous M
    Haematologica; 2019 Nov; 104(11):e497-e501. PubMed ID: 31004018
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5/35++ Vectors.
    Li C; Mishra AS; Gil S; Wang M; Georgakopoulou A; Papayannopoulou T; Hawkins RD; Lieber A
    Mol Ther; 2019 Dec; 27(12):2195-2212. PubMed ID: 31494053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome.
    Kuo CY; Long JD; Campo-Fernandez B; de Oliveira S; Cooper AR; Romero Z; Hoban MD; Joglekar AV; Lill GR; Kaufman ML; Fitz-Gibbon S; Wang X; Hollis RP; Kohn DB
    Cell Rep; 2018 May; 23(9):2606-2616. PubMed ID: 29847792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic gene editing in CD34
    Diez B; Genovese P; Roman-Rodriguez FJ; Alvarez L; Schiroli G; Ugalde L; Rodriguez-Perales S; Sevilla J; Diaz de Heredia C; Holmes MC; Lombardo A; Naldini L; Bueren JA; Rio P
    EMBO Mol Med; 2017 Nov; 9(11):1574-1588. PubMed ID: 28899930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of H1 PAX6
    Wu W; Liu J; Su Z; Li Z; Ma N; Huang K; Zhou T; Wang L
    Biochem Biophys Res Commun; 2018 Aug; 502(4):442-449. PubMed ID: 29807013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TALEN-Mediated Gene Targeting for Cystic Fibrosis-Gene Therapy.
    Xia E; Zhang Y; Cao H; Li J; Duan R; Hu J
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30641980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells.
    Dreyer AK; Hoffmann D; Lachmann N; Ackermann M; Steinemann D; Timm B; Siler U; Reichenbach J; Grez M; Moritz T; Schambach A; Cathomen T
    Biomaterials; 2015 Nov; 69():191-200. PubMed ID: 26295532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High efficiency retroviral mediated gene transduction into single isolated immature and replatable CD34(3+) hematopoietic stem/progenitor cells from human umbilical cord blood.
    Lu L; Xiao M; Clapp DW; Li ZH; Broxmeyer HE
    J Exp Med; 1993 Dec; 178(6):2089-96. PubMed ID: 7504056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Bicistronic TALENs Greatly Improve Genome Editing.
    Martín-Fernández JM; Fleischer A; Vallejo-Diez S; Palomino E; Sánchez-Gilabert A; Ruiz R; Bejarano Y; Llinàs P; Gayá A; Bachiller D
    Curr Protoc Stem Cell Biol; 2020 Mar; 52(1):e104. PubMed ID: 32023363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfection, selection, and colony-picking of human induced pluripotent stem cells TALEN-targeted with a GFP gene into the AAVS1 safe harbor.
    Cerbini T; Luo Y; Rao MS; Zou J
    J Vis Exp; 2015 Feb; (96):. PubMed ID: 25741760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient Genome Editing in Induced Pluripotent Stem Cells with Engineered Nucleases In Vitro.
    Termglinchan V; Seeger T; Chen C; Wu JC; Karakikes I
    Methods Mol Biol; 2017; 1521():55-68. PubMed ID: 27910041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.